Discover 1,272 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
for
Genetics of Drug Metabolism
Location: Scottsdale AZ, El Cajon CA, Arcadia CA, Austin TX,
Sponsor: Companion Dx Reference Lab, LLC
Sex: All
Age: 18+
Code: NCT02081872
Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Scottsdale AZ, La Jolla CA, Aurora CO, San Mateo CA,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Pancreatic Cancer Early Detection Consortium
for
Pancreas Cancer, Pancreas Cyst,
Location: Scottsdale AZ, La Jolla CA, Orange CA, Newport Beach CA,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 18 - 70+
Code: NCT04970056
Recruiting
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Location: Scottsdale AZ, Denver CO, Tampa FL, Buffalo NY,
Sponsor: Simcha IL-18, Inc.
Sex: All
Age: 18+
Code: NCT04787042
Phase1, Phase2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Scottsdale AZ, La Jolla CA, Los Angeles CA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
for
Advanced Cancer
Location: Scottsdale AZ, Tucson AZ, Santa Monica CA, Palo Alto CA,
Sponsor: Riboscience, LLC.
Sex: All
Age: 18+
Code: NCT05270213
Phase1, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: Scottsdale AZ, Phoenix AZ, Tucson AZ, San Diego CA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
for
Advanced Cancer, Gastric Cancer, Breast Cancer,
Location: Scottsdale AZ, Los Angeles CA, Birmingham AL,
Sponsor: Minneamrita Therapeutics LLC
Sex: All
Age: 18+
Code: NCT03129139
Phase1, Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Scottsdale AZ, Tucson AZ, Las Vegas NV, La Jolla CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
A Study of PYX-201 in Advanced Solid Tumors
for
Solid Tumor, Advanced Solid Tumor
Location: Scottsdale AZ, Los Angeles CA, Denver CO,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT05720117
Phase1, Recruiting
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
for
Advanced/Metastatic Solid Tumors
Location: Scottsdale AZ, Irvine CA, Duarte CA, Houston TX,
Sponsor: Adagene Inc
Sex: All
Age: 18+
Code: NCT05405595
Phase1, Phase2, Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Scottsdale AZ, Phoenix AZ, La Jolla CA, Duarte CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase3, Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Scottsdale AZ, Tucson AZ, Los Angeles CA, Sacramento CA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase1, Recruiting
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Scottsdale AZ, Salt Lake City UT, Fairfax VA,
Sponsor: Peel Therapeutics Inc
Sex: All
Age: 18+
Code: NCT05329103
Phase1, Recruiting
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents